Nafarelin acetate

Fig. 10). A phase separation microencapsulation technique was used to formulate nafarelin acetate in 50 50, 69 31, and 45 55 DL-lactide/glycolide copolymers (120). [Pg.26]

FIGURE 10 Plasma profile of nafarelin acetate and biological response parameter in female Rhesus monkeys after injection with 100 mg of 55 45 lactide/glycolide microspheres. (From Ref. 118.)... [Pg.26]

N. I. Chu, R. L. Chan, K. M. Hama, M. D. Chaplin, Disposition of Nafarelin Acetate, a Potent Agonist of Luteinizing Hormone-Releasing Hormone, in Rats and Rhesus Monkeys , Drug Metab. Dispos. 1985, 13, 560 - 565. [Pg.380]

Leuprorelin acetate Nafarelin acetate C2H5-NH-Pro-Arg-Leu-D-Leu-Tyr-Ser-Trp-His-5oxo pro NH2-Gly-Pro-Arg-Leu-D-Ala-Tyr-Ser-Try-His-5oxo pro 1... [Pg.345]

Gonadotropin-releasing hormone (GnRH) analogs buserelin acetate goserelin acetate leuprolide acetate nafarelin acetate... [Pg.606]

Drug interactions The label states that no pharmacokinetic-based drug-drug interaction studies have been conducted with Synarel. However, because nafarelin acetate is a peptide that is primarily degraded by peptidase and not by cytochrome P-450 enzymes, drug interactions would not be expected to occur. [Pg.234]

Nafarelin acetate, gonadotropin-releasing hormone (GnRH) agonist... [Pg.459]

Synarel nasal solution contains nafarelin acetate (2 mg/mL, content expressed as nafarelin base) in a solution of benzalkonium chloride, glacial acetic acid, sodium... [Pg.159]

Big Chemical Encyclopedia